medium chain triglyceride Report issue

Small molecule Approved FDA
AACT ChEMBL

Active Ingredient History

NOW
  • Now
Medium-chain triglycerides (MCTs) are triglycerides with two or three fatty acids having an aliphatic tail of 6–12 carbon atoms, i.e. medium-chain fatty acids (MCFAs). Rich food sources for commercial extraction of MCTs include palm kernel oil and coconut oil.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanisms of Action: Missing data
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Alternative names

medium chain triglyceride | medium chain triglycerides | medium-chain triglycerides | triglycerides, medium-chain

Organizations (47)

Research & Development (46)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (18)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (18)


 

Attention Deficit and Disruptive Behavior Disorders (Phase 4)

Cardiac Surgical Procedures (Phase 2/Phase 3)

Cerebral Palsy (Phase 4)

Constipation (Phase 4)

COVID-19 (Phase 3)

Crohn Disease (Phase 4)

Enteral Nutrition (Phase 4)

Epilepsy (Phase 2)

Fractures, Bone (Phase 2)

Infant, Premature, Diseases (Phase 2)

Infections (Phase 1)

Inflammation (Phase 2/Phase 3)

Kidney Diseases (Phase 1)

MELAS Syndrome (Early Phase 1)

Mitochondrial Diseases (Early Phase 1)

Parkinson Disease (Phase 1)

Seizures (Phase 2)

Sports Medicine (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 30
  • # of Trial Organizations: 46

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue